Turmeric for Patients With Basal Joint Arthritis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorMassachusetts General Hospital

About this trial

The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

40 years of age or older

English fluency and literacy

Seeking care for basal joint pain

Tender over basal joint

Disqualifiers

Secondary gains (litigations or worker compensation) procedures that may interfere with patients' motivation for treatment

Inability or unwillingness to participate in a trial study

Rheumatoid Arthritis or other inflammatory disorder diagnoses

Post-traumatic osteoarthritis

Trial design

Design model

Parallel

Treatments tested in this trial

  • Turmeric

    Dietary supplement

    Subjects will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.

  • Placebo

    Other intervention

    Subjects in the control group will receive a placebo 3 times per day for 6 weeks.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: TurmericExperimental treatment 1 intervention
Group B: ControlPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in baseline pain intensity

0-10 ordinal rating of pain intensity

Time frame
Enrollment, 6 weeks, and 3 months
2

Change in baseline disability

Disability measured by the QuickDASH

Time frame
Enrollment, 6 weeks, and 3 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.